Literature DB >> 709001

Effects of somatostatin on gastric acid secretion and on lipid and carbohydrate metabolism in the rat.

W G Linscheer, K L Raheja.   

Abstract

1 Studies were conducted to examine the effects of somatostatin on pentagastrin-induced gastric acid secretion, and on bile, plasma and liver lipid composition in the rat. 2 In addition, liver glycogen and plasma glucose concentrations were measured. 3 Somatostatin was administered intravenously as a bolus (100 microgram) at the start of the experiment followed by a continuous infusion (50 microgram/h) for 2 h. 4 Controls were infused with isotonic saline (1 ml/h) throughout the experiment. Gastric secretions and bile were collected during the infusions. 5 Somatostatin significantly decreased the volume of gastric secretion as well as total gastric acid output but it had no effect on bile or bile lipid composition. 6 Plasma and liver lipids were not affected. Plasma glucose concentrations were significantly elevated but liver glycogen was not changed. 7 Our results suggest that somatostatin probably decreases glucose uptake by peripheral tissue. The effect of somatostatin on bile composition and glucose levels in the rat is different from observations reported in other species.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 709001      PMCID: PMC1668325          DOI: 10.1111/j.1476-5381.1978.tb17306.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  ENZYMATIC DETERMINATION AND THIN-LAYER CHROMATOGRAPHY OF BILE ACIDS IN BLOOD.

Authors:  T IWATA; K YAMASAKI
Journal:  J Biochem       Date:  1964-11       Impact factor: 3.387

2.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

3.  Micromethod for the direct determination of serum triglycerides.

Authors:  E VAN HANDEL; D B ZILVERSMIT
Journal:  J Lab Clin Med       Date:  1957-07

4.  A new method for the direct determination of serum cholesterol.

Authors:  A ZLATKIS; B ZAK; A J BOYLE
Journal:  J Lab Clin Med       Date:  1953-03

5.  Inhibition of gastric acid secretion by somatostatin and analogs in the rat.

Authors:  W Lippmann; L E Borella
Journal:  Pharmacol Res Commun       Date:  1976-10

6.  The effect of somatostatin on glucose uptake and production by rat tissues in vitro.

Authors:  A D Cherrington; M D Caldwell; M R Dietz; J H Exton; O B Crofford
Journal:  Diabetes       Date:  1977-08       Impact factor: 9.461

7.  Direct inhibition of gastric acid and pepsin secretion by growth-hormone release-inhibiting hormone in cats.

Authors:  A Gomez-Pan; J D Reed; M Albinus; B Shaw; R Hall
Journal:  Lancet       Date:  1975-04-19       Impact factor: 79.321

8.  Direct inhibition of gastric acid by growth-hormone release-inhibiting hormone in dogs.

Authors:  A A Barros D'Sa; S R Bloom; J H Baron
Journal:  Lancet       Date:  1975-04-19       Impact factor: 79.321

9.  Effects of somatostatin on the secretion of thyrotropin and prolactin.

Authors:  W Vale; C Rivier; P Brazeau; R Guillemin
Journal:  Endocrinology       Date:  1974-10       Impact factor: 4.736

10.  Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat.

Authors:  M Brown; J Rivier; W Vale
Journal:  Endocrinology       Date:  1976-02       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.